Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biocardia Inc (BCDA)

Biocardia Inc (BCDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 28,828
  • Shares Outstanding, K 12,426
  • Annual Sales, $ 710 K
  • Annual Income, $ -14,710 K
  • 60-Month Beta 1.76
  • Price/Sales 39.90
  • Price/Cash Flow N/A
  • Price/Book 3.89
Trade BCDA with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/20
See More
  • Average Estimate -0.23
  • Number of Estimates 2
  • High Estimate -0.18
  • Low Estimate -0.29
  • Prior Year -0.55
  • Growth Rate Est. (year over year) +58.18%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +12.07%
on 09/08/20
2.65 -14.34%
on 09/21/20
-0.07 (-2.99%)
since 08/28/20
3-Month
2.03 +12.07%
on 09/08/20
2.92 -22.26%
on 08/06/20
-0.13 (-5.42%)
since 06/30/20
52-Week
2.01 +12.94%
on 06/17/20
6.75 -66.37%
on 01/13/20
-1.15 (-33.63%)
since 09/30/19

Most Recent Stories

More News
BioCardia Issued New Patent for Delivery of Cardiac Cell Therapy Through Wrist Artery

BioCardia(R), Inc. [Nasdaq: BCDA] a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the issuance of U.S. Patent No: 10,780,248 for a "Radial...

BCDA : 2.27 (-2.16%)
LD Micro - 360 Companies Set to Present this Week

LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACRX : 1.4200 (-0.70%)
ACER : 2.88 (-7.99%)
ACU : 23.03 (+0.78%)
AT.VN : 1.610 (-0.62%)
AEY : 1.9200 (+1.59%)
ADIL : 2.23 (-26.40%)
ADTX : 1.9500 (+4.84%)
ADXS : 0.4100 (-2.61%)
AEHR : 1.3900 (-0.71%)
AIM : 2.15 (+1.42%)
AIRI : 1.2200 (-3.17%)
ALIM : 4.86 (-6.18%)
ALJJ : 0.7251 (+0.29%)
ALLT : 9.10 (-1.62%)
ARCT : 42.90 (+0.40%)
AREC : 1.5000 (-1.32%)
AMS : 1.8100 (-7.65%)
ANVS : 4.81 (+0.84%)
APEN : 1.6900 (+1.20%)
APM : 2.68 (-43.70%)
AQMS : 0.9110 (-1.47%)
AQB : 4.48 (-1.54%)
ARTL : 0.9926 (+11.53%)
ARHH : 0.8980 (+4.77%)
ATOM : 10.45 (-0.95%)
ATOS : 2.42 (-3.97%)
AUTO : 3.14 (-1.57%)
AYRO : 2.96 (-6.62%)
AZRX : 0.7110 (-1.77%)
BELFA : 11.71 (+4.30%)
BCDA : 2.27 (-2.16%)
BIOC : 4.41 (-2.65%)
BHTG : 1.4500 (+18.85%)
BIOL : 0.2751 (+0.77%)
BKEP : 1.5400 (-3.14%)
ATDS : 0.0091 (-3.19%)
ASUR : 7.55 (+0.80%)
BEER.VN : 0.055 (+10.00%)
ANY : 2.47 (-4.63%)
BioCardia to Present at the LD Micro 500 Virtual Conference on September 1, 2020

BioCardia(R), Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies today announced that Peter Altman, Ph.D., Biocardia's Chief Executive...

BCDA : 2.27 (-2.16%)
BioCardia Reports Second Quarter 2020 Financial Results and Business Highlights

BioCardia(R), Inc. [NASDAQ: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the second...

BCDA : 2.27 (-2.16%)
BioCardia, Inc. (BCDA) May Report Negative Earnings: Know the Trend Ahead of Q2 Release

BioCardia, Inc. (BCDA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

BCDA : 2.27 (-2.16%)
BioCardia To Conduct Mid-Year Conference Call and Corporate Update August 13, 2020

BioCardia, Inc. [NASDAQ:BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced it will be conducting a mid-year corporate update conference...

BCDA : 2.27 (-2.16%)
LD Micro Announces Preliminary List of Presenters for the LD 500

LD Micro today announced the initial list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online.

ACER : 2.88 (-7.99%)
ACU : 23.03 (+0.78%)
AEY : 1.9200 (+1.59%)
ADIL : 2.23 (-26.40%)
ADXS : 0.4100 (-2.61%)
AEHR : 1.3900 (-0.71%)
AIM : 2.15 (+1.42%)
AIRI : 1.2200 (-3.17%)
KERN : 3.64 (-2.15%)
ALIM : 4.86 (-6.18%)
ALLT : 9.10 (-1.62%)
AMS : 1.8100 (-7.65%)
ANVS : 4.81 (+0.84%)
APEN : 1.6900 (+1.20%)
APM : 2.68 (-43.70%)
AQB : 4.48 (-1.54%)
ARTL : 0.9926 (+11.53%)
ARHH : 0.8980 (+4.77%)
ATOM : 10.45 (-0.95%)
ATOS : 2.42 (-3.97%)
ACU.VN : 0.145 (+3.57%)
AUTO : 3.14 (-1.57%)
AYRO : 2.96 (-6.62%)
AYTU : 1.1900 (-0.83%)
AZRX : 0.7110 (-1.77%)
BLDP : 15.10 (unch)
BELFA : 11.71 (+4.30%)
BCDA : 2.27 (-2.16%)
BIOC : 4.41 (-2.65%)
BMRA : 6.93 (-3.35%)
BSGM : 4.93 (+1.02%)
BLNK : 10.31 (+3.20%)
BKEP : 1.5400 (-3.14%)
CLBS : 1.8000 (-4.26%)
CLXT : 5.49 (-4.69%)
ASUR : 7.55 (+0.80%)
BLGO : 0.1502 (-3.03%)
BioCardia Announces CardiAMP Heart Failure Pivotal Trial Continues with First Patient Randomized in COVID-19 Era

BioCardia(R), Inc., (OTC: BCDA), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced that the Company has resumed cases in the CardiAMP Heart...

BCDA : 2.27 (-2.16%)
BioCardia Announces Pricing of $10 Million Public Offering

BioCardia, Inc. NasdaqCM: BCDA (the "Company"), a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today announced the pricing of its public offering of 4,762,000...

BCDA : 2.27 (-2.16%)
BioCardia Reports First Quarter 2020 Financial Results and Business Highlights

BioCardia(R), Inc. [Nasdaq: BCDA], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the first...

BCDA : 2.27 (-2.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

BioCardia Inc. is engaged in developing regenerative biologic therapies to treat cardiovascular disease. The company's product candidate consists of CardiAMP(TM), CardiALLO(TM) and Helix Biotherapeutic Delivery System(TM) in clinical development stage. BioCardia Inc. is headquartered in San Carlos, California....

See More

Key Turning Points

2nd Resistance Point 2.48
1st Resistance Point 2.37
Last Price 2.27
1st Support Level 2.19
2nd Support Level 2.12

See More

52-Week High 6.75
Fibonacci 61.8% 4.94
Fibonacci 50% 4.38
Fibonacci 38.2% 3.82
Last Price 2.27
52-Week Low 2.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar